Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

BrainCells' Neurogenesis Work Brings In $17.7M In First Round

July 18, 2005

By Jennifer Boggs

Trading Heavy As Momenta's Stock Price Jumps Once Again

July 18, 2005

By Jennifer Boggs

BrainCells' Neurogenesis Work Brings In $17.7M In First Round

July 18, 2005

By Jennifer Boggs

Trading Heavy As Momenta's Stock Price Jumps Once Again

July 18, 2005

By Jennifer Boggs

Genzyme Beats Estimates; Revenues Jump 22 Percent

July 15, 2005

By Jennifer Boggs

Growing product sales and an expanding pipeline led Genzyme Corp. to report solid earnings for the second quarter, once again beating consensus estimates. (BioWorld Today)

Genzyme Beats Estimates; Revenues Jump 22 Percent

July 15, 2005

By Jennifer Boggs

Growing product sales and an expanding pipeline led Genzyme Corp. to report solid earnings for the second quarter, once again beating consensus estimates. (BioWorld Today)

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 14, 2025.
NME Digest: Q2 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...
Aussie gene therapy company emerges from stealth
BioWorld
Aussie gene therapy company Mirugen Pty Ltd. has emerged from stealth mode from the Center for Eye Research Australia in Melbourne, toting a AU$4.5 million...